{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:08:41Z","timestamp":1790968121686,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI030240"],"award-info":[{"award-number":["PI030240"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI061246"],"award-info":[{"award-number":["PI061246"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RCESP C03\/09"],"award-info":[{"award-number":["RCESP C03\/09"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RTICESP C03\/10"],"award-info":[{"award-number":["RTICESP C03\/10"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RTIC RD06\/0020\/0095"],"award-info":[{"award-number":["RTIC RD06\/0020\/0095"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD12\/0036\/0056"],"award-info":[{"award-number":["RD12\/0036\/0056"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CIBERESP"],"award-info":[{"award-number":["CIBERESP"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d\u2019Ajuts Universitaris i de Recerca","doi-asserted-by":"crossref","award":["2005SGR00695"],"award-info":[{"award-number":["2005SGR00695"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d\u2019Ajuts Universitaris i de Recerca","doi-asserted-by":"crossref","award":["2009SGR126"],"award-info":[{"award-number":["2009SGR126"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d\u2019Ajuts Universitaris i de Recerca","doi-asserted-by":"crossref","award":["2014SGR1077"],"award-info":[{"award-number":["2014SGR1077"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d\u2019Ajuts Universitaris i de Recerca","doi-asserted-by":"crossref","award":["2014SGR2016"],"award-info":[{"award-number":["2014SGR2016"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Marat\u00f3 de TV3 Foundation","award":["051530"],"award-info":[{"award-number":["051530"]}]},{"DOI":"10.13039\/501100014062","name":"Lilly Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014062","id-type":"DOI","asserted-by":"crossref"}]},{"name":"GlaxoSmithKline Biologicals"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.ejca.2015.06.001","type":"journal-article","created":{"date-parts":[[2015,6,30]],"date-time":"2015-06-30T08:05:06Z","timestamp":1435651506000},"page":"1732-1741","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":214,"title":["Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions"],"prefix":"10.1016","volume":"51","author":[{"given":"Beatriz","family":"Serrano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"de Sanjos\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Tous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Quiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nubia","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laia","family":"Alemany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ejca.2015.06.001_b0005","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1470-2045(12)70137-7","article-title":"Global burden of cancers attributable to infections in 2008: a review and synthetic analysis","volume":"13","author":"De Martel","year":"2012","journal-title":"Lancet Oncol"},{"issue":"Suppl. 5","key":"10.1016\/j.ejca.2015.06.001_b0010","doi-asserted-by":"crossref","first-page":"F12","DOI":"10.1016\/j.vaccine.2012.07.055","article-title":"Global burden of human papillomavirus and related diseases","volume":"30","author":"Forman","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.ejca.2015.06.001_b0015","unstructured":"IARC. Monographs on the evaluation of carcinogenic risks to humans. A review of Human Carcinogens. Part B: Biological Agents, Vol 100. Lyon, France: International Agency for Research on Cancer, 2011. Available at: <http:\/\/monographs.iarc.fr\/ENG\/Monographs\/vol100B\/mono100B.pdf>; [Internet] [accessed 02.15]."},{"key":"10.1016\/j.ejca.2015.06.001_b0020","unstructured":"Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available at: <http:\/\/globocan.iarc.fr>; [Internet] [accessed 02.15]."},{"issue":"Suppl. 3","key":"10.1016\/j.ejca.2015.06.001_b0025","article-title":"HPV type-distribution in women with and without cervical neoplastic diseases","volume":"24","author":"Clifford","year":"2006","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.ejca.2015.06.001_b0030","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"issue":"5","key":"10.1016\/j.ejca.2015.06.001_b0035","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/jnci\/djj067","article-title":"Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention","volume":"98","author":"Castellsagu\u00e9","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"16","key":"10.1016\/j.ejca.2015.06.001_b0040","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1016\/j.ejca.2013.06.033","article-title":"Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva","volume":"49","author":"de Sanjos\u00e9","year":"2013","journal-title":"Eur J Cancer"},{"issue":"7","key":"10.1016\/j.ejca.2015.06.001_b0045","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/ijc.24116","article-title":"Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis","volume":"124","author":"De Vuyst","year":"2009","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2015.06.001_b0050","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ijc.25396","article-title":"Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication","volume":"128","author":"Li","year":"2011","journal-title":"Int J Cancer"},{"issue":"11","key":"10.1016\/j.ejca.2015.06.001_b0055","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"De Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2015.06.001_b0060","unstructured":"World Health Organization (WHO). Human papillomavirus vaccines WHO position paper. Geneva: World Health Organization, 2014, Available at:< http:\/\/www.who.int\/wer\/2014\/wer8943.pdf?ua=1>; [Internet] [accessed 02.15]."},{"key":"10.1016\/j.ejca.2015.06.001_b0065","unstructured":"Press Announcements - FDA approves Gardasil 9 for prevention of certain cancers caused by five additional types of HPV [Internet]. Available at: <http:\/\/www.fda.gov\/newsevents\/newsroom\/pressannouncements\/ucm426485.htm>; [Internet] [accessed 02.15]."},{"issue":"8","key":"10.1016\/j.ejca.2015.06.001_b0070","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1405044","article-title":"A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women","volume":"372","author":"Joura","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2015.06.001_b0075","unstructured":"National Library of Medicine (NLM), 2015. United States. Available at: ClinicalTrials.gov. Available at: <https:\/\/www.clinicaltrials.gov\/ct2\/results?term=Gardasil9&Search=Search>; [Internet] [accessed .02.15]."},{"issue":"9","key":"10.1016\/j.ejca.2015.06.001_b0080","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1002\/ijc.28541","article-title":"Potential cost-effectiveness of the nonavalent human papillomavirus (HPV) vaccine","volume":"134","author":"Drolet","year":"2014","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2015.06.001_b0085","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/ijc.28963","article-title":"Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide","volume":"136","author":"Alemany","year":"2015","journal-title":"Int J Cancer"},{"issue":"16","key":"10.1016\/j.ejca.2015.06.001_b0090","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1016\/j.ejca.2014.07.018","article-title":"Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples","volume":"50","author":"Alemany","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2015.06.001_b0095","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jviromet.2015.01.001","article-title":"The original SPF10 LiPA25 algorithm is more sensitive and suitable for epidemiologic HPV research than the SPF10 INNO-LiPA Extra","volume":"215\u2013216","author":"Geraets","year":"2015","journal-title":"J Virol Methods"},{"issue":"7","key":"10.1016\/j.ejca.2015.06.001_b0100","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1158\/1055-9965.EPI-07-2922","article-title":"A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States","volume":"17","author":"Insinga","year":"2008","journal-title":"Cancer Epidemiol Biomark"},{"issue":"9","key":"10.1016\/j.ejca.2015.06.001_b0105","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1002\/ijc.24528","article-title":"Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants","volume":"125","author":"Wentzensen","year":"2009","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/j.ejca.2015.06.001_b0110","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.ejca.2015.01.058","article-title":"High-sensitivity human papilloma virus genotyping reveals near universal positivity in anal squamous cell carcinoma: different implications for vaccine prevention and prognosis","volume":"51","author":"Baricevic","year":"2015","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.ejca.2015.06.001_b0115","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/ijc.25671","article-title":"Human papillomavirus genotype distribution in anal cancer in France: the EDiTH V study","volume":"129","author":"Abramowitz","year":"2011","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2015.06.001_b0120","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1750-9378-7-38","article-title":"Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease","volume":"7","author":"Serrano","year":"2012","journal-title":"Infect Agent Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2015.06.001_b0125","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ygyno.2011.03.016","article-title":"In situ and invasive squamous cell carcinoma of the vulva in Denmark 1978\u20132007-a nationwide population-based study","volume":"122","author":"Baandrup","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"8","key":"10.1016\/j.ejca.2015.06.001_b0130","first-page":"613","article-title":"Trends in vulvar neoplasia. Increasing incidence of vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva in young women","volume":"45","author":"Joura","year":"2000","journal-title":"J Reprod Med"},{"issue":"12P2","key":"10.1016\/j.ejca.2015.06.001_b0135","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1016\/j.lpm.2014.10.001","article-title":"HPV in genital cancers (at the exception of cervical cancer) and anal cancers","volume":"43","author":"de Sanjos\u00e9","year":"2014","journal-title":"Presse Medicale"},{"key":"10.1016\/j.ejca.2015.06.001_b0140","unstructured":"Bruni L, Barrionuevo-Rosas L, Albero G, Aldea M, Serrano B, Valencia S, et al. ICO Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World. Summary Report 2015- 04-08. Available at: <http:\/\/hpvcentre.net\/statistics\/reports\/XWX.pdf> [Internet] [accessed 02.15]."},{"issue":"4","key":"10.1016\/j.ejca.2015.06.001_b0145","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/AOG.0000000000000171","article-title":"Human papillomavirus genotype prevalence in invasive vaginal cancer from a registry-based population","volume":"123","author":"Sinno","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ejca.2015.06.001_b0150","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1158\/1055-9965.EPI-09-0067","article-title":"Human papillomavirus infections and vulvar disease development","volume":"18","author":"Garland","year":"2009","journal-title":"Cancer Epidemiol Biomark"},{"issue":"8","key":"10.1016\/j.ejca.2015.06.001_b0155","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1158\/0008-5472.CAN-08-4192","article-title":"Detection of precancerous cervical lesions is differential by human papillomavirus type","volume":"69","author":"Safaeian","year":"2009","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.ejca.2015.06.001_b0160","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1158\/1055-9965.EPI-13-0053","article-title":"Age-specific occurrence of HPV16- and HPV18-related cervical cancer","volume":"22","author":"De Sanjose","year":"2013","journal-title":"Cancer Epidemiol Biomark"},{"issue":"10","key":"10.1016\/j.ejca.2015.06.001_b0165","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/ijc.27485","article-title":"Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer","volume":"131","author":"Guan","year":"2012","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2015.06.001_b0170","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/path.4405","article-title":"Pathogenic role of the eight probably\/possibly carcinogenic HPV types 26, 53, 66, 67, 68, 70, 73 and 82 in cervical cancer","volume":"234","author":"Halec","year":"2014","journal-title":"J Pathol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804915004918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804915004918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T11:48:25Z","timestamp":1589543305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804915004918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":34,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0959804915004918"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2015.06.001","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2015.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}